1 |
Levocarnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
003 3件: 3 , 53, 97 💬 |
2 |
Levocarnitine propyl hydrochloride |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 1件: 97 💬 |
3 |
Valproate, levocarnitine |
Levocarnitine |
4件: D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 1件: 3 💬 |
4 |
Valproic acid and levocarnitine |
Levocarnitine |
4件: D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 1件: 3 💬 |